Cosmo served as Co-Founder and Chief Executive Officer of Beckley Psytech Ltd.

Cosmo is a drug development entrepreneur dedicated to unlocking the medical potential of psychoactive substances in order to help patients in need. Cosmo worked closely with the Beckley Foundation for over 10 years and, in 2016, he co-founded Beckley Research & Innovations to develop ethical business models focused on scientific research into medical cannabis and psychedelics.

Cosmo subsequently served as Co-Founder and Managing Director of Beckley Canopy Therapeutics, a cannabis-based drug development company, and Spectrum Biomedical UK, a medical cannabis distribution company. In 2019, both of these companies were acquired by Canopy Growth Corporation, the world’s largest medical cannabis company.

In 2019, he co-founded Beckley Psytech, a biopharmaceutical company dedicated to developing effective, rapid-acting and accessible psychedelic-based medicines for mental health conditions.